Teva Pharm sees lower than forecast 2015 revenue
December 11, 2014 at 07:26 AM EST
TEL AVIV, Dec 11 (Reuters) - Teva Pharmaceutical Industries , the world's biggest generic drugmaker, forecast 2015 revenue below analysts' expectations and assumes its best-selling multiple sclerosis treatment will face competition in September.